53. シェーグレン症候群 Sjogren syndrome Clinical trials / Disease details

臨床試験数 : 305 / 薬物数 : 325 - (DrugBank : 104) / 標的遺伝子数 : 58 - 標的パスウェイ数 : 188

118 trials found

diseases per page:

Showing 1 to 10 of 118 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-002470-32-NL (EUCTR)	12/12/2022	23/07/2021	NEw Clinical End-points in patients with primary Sjögren’s Syndrome (pSS): an Interventional Trial b ...	NEw Clinical End-points in patients with primary Sjögren’s Syndrome (pSS): an Interventional Trial b ...	Primary Sjögren’s syndrome (pSS) MedDRA version: 21.0;Level: PT;Classification code 10040767;Term: S ...	Trade Name: PLAQUENIL Product Name: Hydroxychloroquine INN or Proposed INN: Hydroxychloroquine Other de ...	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS ( AP-HP)	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	300	Phase 2	Netherlands;Italy
2	NCT05383677 (ClinicalTrials.gov)	October 1, 2022	29/3/2022	Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome	ANIfrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome - Efficacy and Safety ...	Sjogren's Syndrome	Drug: Anifrolumab;Drug: Placebo	University Medical Center Groningen	AstraZeneca	Recruiting	18 Years	N/A	All	30	Phase 2	Netherlands
3	NCT05349214 (ClinicalTrials.gov)	August 4, 2022	8/4/2022	Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren' ...	A Randomized, Double-blind, Placebo Controlled, 3-arm Multicenter Phase 3 Study to Assess the Effica ...	Sjogren Syndrome	Biological: VAY736;Other: Placebo	Novartis Pharmaceuticals	NULL	Recruiting	18 Years	N/A	All	489	Phase 3	United States;Argentina;Australia;Brazil;Bulgaria;Canada;China;France;Germany;Greece;Hungary;India;I ...
4	EUCTR2021-005687-22-SK (EUCTR)	01/08/2022	12/05/2022	A clinical study to investigate ianalumab is effective and safe in the treatment of active Sjögren`s ...	A randomized, double-blind, placebo controlled, 3-arm multicenter phase 3 study to assess the effica ...	Active Sjögren’s syndrome MedDRA version: 21.0;Level: PT;Classification code 10040767;Term: Sjogren' ...	Product Name: ianalumab Product Code: VAY736 INN or Proposed INN: IANALUMAB	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	489	Phase 3	United States;Taiwan;Slovakia;Greece;Spain;Lebanon;Israel;Chile;Colombia;Italy;India;France;Australi ...
5	NCT05350072 (ClinicalTrials.gov)	July 28, 2022	7/4/2022	Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's ...	A Randomized, Double-blind, Placebo Controlled, 2-arm Multicenter Phase 3 Study to Assess the Effica ...	Sjogren Syndrome	Biological: VAY736;Other: Placebo	Novartis Pharmaceuticals	NULL	Recruiting	18 Years	N/A	All	285	Phase 3	United States;Austria;Brazil;China;Czechia;France;Germany;Guatemala;Korea, Republic of;Lithuania;Pol ...
6	EUCTR2021-005687-22-HU (EUCTR)	24/05/2022	11/04/2022	A clinical study to investigate ianalumab is effective and safe in the treatment of active Sjögren`s ...	A randomized, double-blind, placebo controlled, 3-arm multicenter phase 3 study to assess the effica ...	Active Sjögren’s syndrome MedDRA version: 21.0;Level: PT;Classification code 10040767;Term: Sjogren' ...	Product Name: ianalumab Product Code: VAY736 INN or Proposed INN: IANALUMAB	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	489	Phase 3	United States;Taiwan;Slovakia;Greece;Spain;Lebanon;Israel;Chile;Colombia;Italy;India;France;Australi ...
7	JPRN-jRCT2031210484	30/03/2022	14/12/2021	A Study of Nipocalimab in Adults with Primary Sjogren'sSyndrome (pSS)	A Randomized, Placebo-controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety ...	Sjogren's Syndrome	Placebo Placebo infusion will be administered intravenously. Nipocalimab Nipocalimabdose 1 and dose 2 i ...	Nishikawa Kazuko	NULL	Recruiting	>= 18age old	<= 75age old	Both	150	Phase 2	Germany;Spain;Italy;Netherlands;Poland;Portugal;United States Of America;France;Taiwan;Japan
8	ChiCTR2200057578	2022-03-01	2022-03-15	Tofacitinib treatment in patients with primary Sjogren syndrome: a prospective pilot trial	Tofacitinib treatment in patients with primary Sjogren syndrome: a prospective pilot trial	Sjogren Syndrome	Control group:Same dose of hydroxychloroquine sulfate asbefore;Intervention group:Tofacitinib5mg bid ...	Ningbo Medical Center Lihuili Hospital	NULL	Pending	15	70	Both	Control group:60;Intervention group:60;	Phase 4	China
9	EUCTR2021-000665-32-NL (EUCTR)	16/02/2022	21/10/2021	A Study of Nipocalimab in Adults with Primary Sjogren's Syndrome (pSS)	Randomized, Placebo-controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of ...	Primary Sjogren's Syndrome MedDRA version: 21.0;Level: LLT;Classification code 10040766;Term: Sjogre ...	Product Name: Nipocalimab Product Code: M281 INN or Proposed INN: nipocalimab Other descriptive name: J ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 2	Portugal;France;United States;Taiwan;Spain;Poland;Germany;Netherlands;Italy;Japan
10	NCT05113004 (ClinicalTrials.gov)	January 20, 2022	2/11/2021	New Clinical End-points in Patients With Primary Sjögren's Syndrome	NEw Clinical Endpoints in Patients With Primary Sjögren's Syndrome (pSS): an Interventional Trial Ba ...	Primary Sjögren's Syndrome (pSS)	Drug: Hydroxychloroquine 400mg/d;Drug: Leflunomide 20mg/d;Drug: Mycophenolate mofetil 2000mg/d;Drug: Pla ...	Assistance Publique - Hôpitaux de Paris	NULL	Recruiting	18 Years	N/A	All	300	Phase 2	France

First Previous1 2 3 4 5…12Next Last